179 related articles for article (PubMed ID: 11131459)
1. Increased mast cells in hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
Terada T; Matsunaga Y
J Hepatol; 2000 Dec; 33(6):961-6. PubMed ID: 11131459
[TBL] [Abstract][Full Text] [Related]
2. S-100-positive nerve fibers in hepatocellular carcinoma and intrahepatic cholangiocarcinoma: an immunohistochemical study.
Terada T; Matsunaga Y
Pathol Int; 2001 Feb; 51(2):89-93. PubMed ID: 11169146
[TBL] [Abstract][Full Text] [Related]
3. Structural examination of tryptase- and chymase-positive mast cells in livers, containing metastases from gastrointestinal cancers.
Gulubova MV
Clin Exp Metastasis; 2003; 20(7):611-20. PubMed ID: 14669792
[TBL] [Abstract][Full Text] [Related]
4. Tumor-derived trypsin enhances proliferation of intrahepatic cholangiocarcinoma cells by activating protease-activated receptor-2.
Nakanuma S; Tajima H; Okamoto K; Hayashi H; Nakagawara H; Onishi I; Takamura H; Kitagawa H; Fushida S; Tani T; Fujimura T; Kayahara M; Ohta T; Wakayama T; Iseki S; Harada S
Int J Oncol; 2010 Apr; 36(4):793-800. PubMed ID: 20198321
[TBL] [Abstract][Full Text] [Related]
5. Mast cell subpopulations in chronic inflammatory hepatobiliary diseases.
Matsunaga Y; Terada T
Liver; 2000 Apr; 20(2):152-6. PubMed ID: 10847484
[TBL] [Abstract][Full Text] [Related]
6. The diagnostic value of arginase-1 immunostaining in differentiating hepatocellular carcinoma from metastatic carcinoma and cholangiocarcinoma as compared to HepPar-1.
Radwan NA; Ahmed NS
Diagn Pathol; 2012 Oct; 7():149. PubMed ID: 23111165
[TBL] [Abstract][Full Text] [Related]
7. Cellular and stromal characteristics in the scirrhous hepatocellular carcinoma: comparison with hepatocellular carcinomas and intrahepatic cholangiocarcinomas.
Okamura N; Yoshida M; Shibuya A; Sugiura H; Okayasu I; Ohbu M
Pathol Int; 2005 Nov; 55(11):724-31. PubMed ID: 16271085
[TBL] [Abstract][Full Text] [Related]
8. Microvessel density and angiogenesis in primary hepatic malignancies: Differential expression of CD31 and VEGFR-2 in hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
Bösmüller H; Pfefferle V; Bittar Z; Scheble V; Horger M; Sipos B; Fend F
Pathol Res Pract; 2018 Aug; 214(8):1136-1141. PubMed ID: 29935812
[TBL] [Abstract][Full Text] [Related]
9. Distribution of intrahepatic mast cells in various hepatobiliary disorders. An immunohistochemical study.
Yamashiro M; Kouda W; Kono N; Tsuneyama K; Matsui O; Nakanuma Y
Virchows Arch; 1998 Nov; 433(5):471-9. PubMed ID: 9849863
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic features of patients with intrahepatic cholangiocarcinoma who are seropositive for alpha-fetoprotein-L3 and those with combined hepatocellular and cholangiocarcinoma.
Okuda H; Shiratori K; Yamamoto M; Takasaki K; Nakano M
J Gastroenterol Hepatol; 2006 May; 21(5):869-73. PubMed ID: 16704538
[TBL] [Abstract][Full Text] [Related]
11. Comparison of combined hepatocellular and cholangiocarcinoma with hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
Lee WS; Lee KW; Heo JS; Kim SJ; Choi SH; Kim YI; Joh JW
Surg Today; 2006; 36(10):892-7. PubMed ID: 16998683
[TBL] [Abstract][Full Text] [Related]
12. Stromal mast cells and nerve fibers in various chronic liver diseases: relevance to hepatic fibrosis.
Matsunaga Y; Kawasaki H; Terada T
Am J Gastroenterol; 1999 Jul; 94(7):1923-32. PubMed ID: 10406261
[TBL] [Abstract][Full Text] [Related]
13. Intrahepatic cholangiocarcinomas in cirrhosis are hypervascular in comparison with those in normal livers.
Xu J; Igarashi S; Sasaki M; Matsubara T; Yoneda N; Kozaka K; Ikeda H; Kim J; Yu E; Matsui O; Nakanuma Y
Liver Int; 2012 Aug; 32(7):1156-64. PubMed ID: 22417172
[TBL] [Abstract][Full Text] [Related]
14. Double cancer - hepatocellular carcinoma and intrahepatic cholangiocarcinoma with a spindle-cell variant.
Itamoto T; Asahara T; Katayama K; Momisako H; Dohi K; Shimamoto F
J Hepatobiliary Pancreat Surg; 1999; 6(4):422-6. PubMed ID: 10664295
[TBL] [Abstract][Full Text] [Related]
15. Enhanced expression of basement-membrane-type heparan sulfate proteoglycan in tumor fibro-myxoid stroma of intrahepatic cholangiocarcinoma.
Sabit H; Tsuneyama K; Shimonishi T; Harada K; Cheng J; Ida H; Saku T; Saito K; Nakanuma Y
Pathol Int; 2001 Apr; 51(4):248-56. PubMed ID: 11350606
[TBL] [Abstract][Full Text] [Related]
16. Intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma: a Western experience.
Portolani N; Baiocchi GL; Coniglio A; Piardi T; Grazioli L; Benetti A; Ferrari Bravo A; Giulini SM
Ann Surg Oncol; 2008 Jul; 15(7):1880-90. PubMed ID: 18443881
[TBL] [Abstract][Full Text] [Related]
17. Prognostic values of tissue-resident CD8
Chen L; Huang H; Huang Z; Chen J; Liu Y; Wu Y; Li A; Ge J; Fang Z; Xu B; Zheng X; Wu C
World J Surg Oncol; 2023 Apr; 21(1):124. PubMed ID: 37024870
[TBL] [Abstract][Full Text] [Related]
18. Protein expression of double-stranded RNA-activated protein kinase (PKR) in intrahepatic bile ducts in normal adult livers, fetal livers, primary biliary cirrhosis, hepatolithiasis and intrahepatic cholangiocarcinoma.
Terada T; Ueyama J; Ukita Y; Ohta T
Liver; 2000 Dec; 20(6):450-7. PubMed ID: 11169059
[TBL] [Abstract][Full Text] [Related]
19. Glypican-3 is a useful diagnostic marker for a component of hepatocellular carcinoma in human liver cancer.
Shirakawa H; Kuronuma T; Nishimura Y; Hasebe T; Nakano M; Gotohda N; Takahashi S; Nakagohri T; Konishi M; Kobayashi N; Kinoshita T; Nakatsura T
Int J Oncol; 2009 Mar; 34(3):649-56. PubMed ID: 19212669
[TBL] [Abstract][Full Text] [Related]
20. The relationship of tryptase- and chymase-positive mast cells to angiogenesis in stage I non-small cell lung cancer.
Ibaraki T; Muramatsu M; Takai S; Jin D; Maruyama H; Orino T; Katsumata T; Miyazaki M
Eur J Cardiothorac Surg; 2005 Oct; 28(4):617-21. PubMed ID: 16125954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
